Aurinia Pharmaceuticals Inc — Balance Sheet (NASDAQ:AUPH) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 463.66 M543.37 M470.86 M548.06 M550.64 M751.59 M Total liabilities 55.91 M64.28 M65.42 M170.11 M173.17 M170.26 M Total equity 407.75 M479.09 M405.44 M377.95 M377.48 M581.33 M Total liabilities & shareholders' equities 463.66 M543.37 M470.86 M548.06 M550.64 M751.59 M Total debt —————— Net debt ——————

Notícias

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Why Is Aurinia Pharmaceuticals (AUPH) Stock Dropping After Strong Quarter? - Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharma earnings beat by $1.38, revenue topped estimates

Resultados da Aurinia em foco: medicamento para lúpus pode manter crescimento?

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

CRISPR Therapeutics Stock Sees RS Rating Rise To 73

Neurocrine Biosciences (NBIX) Lags Q4 Earnings Estimates

AI Standout Broadcom Earns Spot In Sector Leaders, Leads 16 Onto Best Stock Lists

Aerospace/Defense Play Karmen Leads 19 To Best Stock Lists Including IBD 50, Stock Spotlight

This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base